Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers


Agilent Technologies Inc. (NYSE: A) today announced the launch of the newest instrument in its Raman technology portfolio. The new Agilent Vaya Raman raw material identity verification system is a handheld instrument that accelerates quality control testing in the pharmaceutical and biopharmaceutical industries.

Vaya verifies raw material identity through unopened transparent and non-transparent packaging, testing more containers for the same cost by reducing the need for sampling. Incoming goods can be tested quickly in the warehouse on receipt, reducing operator time and sample-handling booth usage. Testing through sealed containers also avoids handler exposure to high potency APIs and maintains the shelf life of sterile contents, helping to prevent unnecessary waste.

“Improving the speed and efficiency of raw material testing has a major impact on pharma and biopharma manufacturing,” said Paul Loeffen, Agilent vice president and general manager of the company’s Molecular Spectroscopy Division. “Testing requirements are trending toward higher volumes, even 100% of containers in many cases, and conventional techniques can be extremely resource-intensive. Vaya’s through-container capability bypasses the bottlenecks, offering our customers a significant cost- and resource-saving solution.”

Vaya is the first true through-barrier handheld Raman instrument, incorporating Agilent’s spatially offset Raman spectroscopy (SORS) technology for fast ID of incoming goods through opaque containers in a GMP ready package. Vaya combines SORS with conventional Raman spectroscopy for maximum compatibility with a wide range of packaging–from clear glass vials and plastic bags to opaque plastics and paper sacks.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200331005144/en/

Agilent Technologies Inc. Aktie

131,00 €
-1,06 %
Einen Verlust von -1,06 % verzeichnet heute die Agilent Technologies Inc. Aktie.
Derzeit ist die Community gegenüber der Agilent Technologies Inc. Aktie mit 16 Buy-Einschätzungen und 4 Sell-Einschätzungen positiv gestimmt.
Ein positives Kurspotenzial für Agilent Technologies Inc. ist gegeben, mit einem Kursziel von 134 € über dem aktuellen Kurs von 131.0 €.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare